Dianthus Therapeutics Inc...

NASDAQ: DNTH · Real-Time Price · USD
20.71
0.46 (2.27%)
At close: Aug 15, 2025, 3:59 PM
20.74
0.14%
After-hours: Aug 15, 2025, 04:10 PM EDT

Dianthus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-31.63M -29.51M -28.44M -25.17M -17.61M -13.75M -10.56M -14.76M -3.28M -29.17M -10.12M -16.06M -17.27M -22.95M -19.29M -17.43M -16.93M -17.49M
Depreciation & Amortization
99K 133K 78K -87K 111K 107K 103K 19K 84K 1.21M 49K 1.21M 1.2M 1.21M 535K 532K 479K 474K
Stock-Based Compensation
5.71M 5.32M 3.92M 3.84M 3.1M 2.04M 726K 1.18M 462K 533K 513K n/a n/a 1.91M 2.18M 3.8M 2.13M 2.19M
Other Working Capital
-998K 30K -4.58M 12.23M -2.16M 567K -3.47M 9.9M 188K -2.69M -926K -1.07M -345K -1.42M -348K -1.29M 1.44M -611K
Other Non-Cash Items
-1.12M -1.9M -2.58M -6.74M -422K -518K -1.47M 4.68M -2.91M 15.43M -402K 3.48M 6.74M 3.04M 2.18M 4.94M 3.66M 306K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 944K n/a -1.01M n/a n/a -3.4M -6.63M n/a n/a n/a n/a n/a
Change in Working Capital
3.05M -1.66M -422K 19.57M 289K -2.82M -1.59M 10.38M -79K -3.85M 1.1M -541K -2.74M -21K 806K -1.17M 1.09M -2.26M
Operating Cash Flow
-23.89M -27.63M -27.44M -8.59M -14.53M -14.94M -11.85M 1.5M -6.54M -19.96M -8.85M -13.81M -16.85M -19.74M -15.69M -14.07M -13M -16.77M
Capital Expenditures
-46K -24K -31K -25K -17K -32K -10K 145K -21K -245K -29K -158K -129K -27K -15K -1.13M -111K -7K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a -5.38M 3.87M 1.51M -127K n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-33.11M -67.32M -108.08M -278.34M -6.81M -20.48M -26.23M -21.43M -9.77M -9.77M -14.64M -19.6M n/a -40.12M -45.31M n/a n/a n/a
Sales Maturities Of Investments
59.6M 82.14M 85M 19M 8M 15M 18M 9.79M 15M 35M 2M 35M n/a n/a 35M 17.5M 30M 7.5M
Other Investing Acitivies
n/a n/a n/a -196K n/a n/a n/a n/a 10.01M n/a 127K n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
26.45M 14.79M -23.11M -259.36M 1.17M -5.51M -8.24M -16.88M 18.87M 26.5M -12.66M 15.24M -129K -40.14M -10.32M 16.37M 29.89M 7.49M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a 15.64M n/a -15.64M n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a -217.58M -12.15M -4.87M 66.44M n/a n/a -3.08M n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow
568K 161K 39.68M 296K -2.2M 217.85M -4.87M 154.08M n/a -15.64M 115K 2.76M 49K n/a 124K 203K 88.86M 418K
Net Cash Flow
3.12M -12.68M -10.88M -280.5M -15.55M 197.4M -24.96M 94.65M 12.33M -7.32M -21.52M 4.2M -16.93M -59.88M -25.89M 725K 103.97M -8.86M
Free Cash Flow
-23.94M -27.65M -27.48M -21.29M -14.54M -14.97M -11.86M 1.64M -6.57M -20.2M -8.88M -13.97M -16.98M -19.77M -15.71M -15.2M -13.11M -16.78M